Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study
Tapper, E. B., Bacon, B. R., Curry, M. P., Dieterich, D. T., Flamm, S. L., Guest, L. E., Kowdley, K. V., Lee, Y., Tsai, N. C., Younossi, Z. M., Afdhal, N. H.
Published in Journal of viral hepatitis (01.01.2017)
Published in Journal of viral hepatitis (01.01.2017)
Get full text
Journal Article